These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12921247)

  • 1. Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management.
    McBride BF; White CM
    Pharmacotherapy; 2003 Aug; 23(8):997-1020. PubMed ID: 12921247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for acute decompensated heart failure.
    Southworth MR
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive Heart Failure.
    Scott MC; Winters ME
    Emerg Med Clin North Am; 2015 Aug; 33(3):553-62. PubMed ID: 26226866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of acute heart failure: update and perspectives].
    Link A; Pöss J; Böhm M
    Dtsch Med Wochenschr; 2012 May; 137(21):1126-9. PubMed ID: 22588659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in chemical pharmacotherapy for managing acute decompensated heart failure.
    Yandrapalli S; Tariq S; Aronow WS
    Expert Opin Pharmacother; 2017 Apr; 18(5):471-485. PubMed ID: 28276970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan: a review of its use in the management of acute decompensated heart failure.
    Innes CA; Wagstaff AJ
    Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.
    Altenberger J; Gustafsson F; Harjola VP; Karason K; Kindgen-Milles D; Kivikko M; Malfatto G; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
    J Cardiovasc Pharmacol; 2018 Mar; 71(3):129-136. PubMed ID: 28817484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for acute decompensated heart failure treatment.
    DiDomenico RJ; Park HY; Southworth MR; Eyrich HM; Lewis RK; Finley JM; Schumock GT
    Ann Pharmacother; 2004 Apr; 38(4):649-60. PubMed ID: 14982975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic strategies to preserve renal function in acute decompensated heart failure.
    Kumar S; Taylor DO
    Curr Heart Fail Rep; 2015 Feb; 12(1):1-6. PubMed ID: 25417180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of B-type natriuretic peptide in heart failure.
    Nappi JM
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):461-5. PubMed ID: 14717391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR
    Am J Cardiol; 2005 Sep; 96(6A):59G-67G. PubMed ID: 16181824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL; Fitzpatrick JT
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic approach to acute decompensated heart failure.
    Kapoor JR; Perazella MA
    Am J Med; 2007 Feb; 120(2):121-7. PubMed ID: 17275448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.